Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-23-003513
Filing Date
2023-04-11
Accepted
2023-04-11 16:25:32
Documents
2
Period of Report
2023-04-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1807
2 POWER OF ATTORNEY poaswilliams.txt EX-24 3564
  Complete submission text file 0001562180-23-003513.txt   6769
Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39941 | Film No.: 23813672

Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)